Influence of parasite load on the ability of type 1 T cells to control Leishmania major infection

Infection and Immunity

Volumn 70, Issue 2, 2002, Pages 498-503

  Hondowicz, Brian ^a   Scott, Phillip ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL TRANSFER; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; IMMUNE RESPONSE; IMMUNITY; INFECTION CONTROL; LEISHMANIA MAJOR; LEISHMANIASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; CHRONIC DISEASE; FEMALE; INTERLEUKIN-12; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LYMPHOCYTE COUNT; MICE; MICE, INBRED BALB C; MICE, SCID; TH1 CELLS; TH2 CELLS; TIME FACTORS;

EID: 0036153523     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.2.498-503.2002     Document Type: Article

References (40)

1. Transforming growth factor-β as a virulence mechanism for Leishmania braziliensis
2. Transforming growth factor-β in leishmanial infection: A parasite escape mechanism
3. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major
4. Extent of T cell receptor ligation can determine the functional differentiation of naïve CD4+ T cells
5. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis
6. Experimental cutaneous leishmaniasis. II. A possible role for prostaglandins in exacerbation of disease in Leishmania major-infected BALB/c mice
7. A role for Lyt2+ T cells in resistance to cutaneous leishmaniasis in immunized mice
8. Antigen-pulsed epidermal Langerhans cells protect susceptible mice from infection with the intracellular parasite Leishmania major
9. A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigenpresenting cells
10. Requirements for the maintenance of Th1 immunity in vivo following DNA vaccination: A potential immunoregulatory role for CD8+ T cells
11. Cure of progressive murine leishmaniasis: Interleukin 4 dominance is abolished by transient CD4(+) T cell depletion and T helper cell type 1-selective cytokine therapy
12. Recombinant interleukin 12 cures mice infected with Leishmania major
13. Reconstitution of leishmania immunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines
14. The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model
15. Impaired interleukin 4 signaling in T helper type 1 cells
16. The role of IL-10 in promoting disease progression in leishmaniasis
17. Successful therapy of chronic, nonhealing murine cutaneous leishmaniasis with sodium stibogluconate and gamma interferon depends on continued interleukin-12 production
18. Parasite dose determines the Th1/Th2 nature of the response to Leishmania major independently of infection route and strain of host or parasite
19. Murine cutaneous leishmaniasis: Resistance in reconstituted nude mice and several F1 hybrids infected with Leishmania tropica major
20. Cutaneous leishmaniasis in mice: Disease patterns in reconstituted nude mice of several genotypes infected with Leishmania tropica
21. Resistance and abrogation of resistance to cutaneous leishmaniasis in reconstituted BALB/c nude mice
22. Analysis of variables associated with promotion of resistance and its abrogation in T cell-reconstituted nude mice infected with Leishmania major
23. Resistance to cutaneous leishmaniasis in nude mice injected with L3T4+ T cells but not with Ly-2+ T cells
24. Role of T cell subsets during the recall of immunologic memory to Leishmania major
25. Signaling and transcription in T helper development
26. Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and Pentostam
27. Depletion of interleukin-4 in BALB/c mice with established Leishmania major infections increases the efficacy of antimony therapy and promotes Th1-like responses
28. The molecular basis of T helper 1 and T helper 2 cell differentiation
29. The relationship between humoral and cell-mediated immunity
30. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity
31. Arachidonic acid metabolism by murine peritoneal macrophages infected with Leishmania donovani: In vitro evidence for parasite-induced alterations in cyclooxygenase and lipoxygenase pathways
32. The regulation of immunity to Leishmania major
33. Identification of an infective stage of Leishmania promastigotes
34. T helper cell development and regulation in experimental cutaneous leishmaniasis
35. Experimental cutaneous leishmaniasis: Induction and regulation of T cells following infection of mice with Leishmania major
36. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes
37. An in vitro model for infection with Leishmania major that mimics the immune response in mice
38. Resolution of cutaneous leishmaniasis: Interleukin 12 initiates a protective Th1 immune response
39. Reconstitution of C.B-17 scid mice with BALB/c T cells initiates a T helper type-1 response and renders them capable of healing Leishmania major infection
40. Leishmania major-infected murine langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous leishmaniasis